JUSTIFICATION OF NITROXOLINE APPLICATION IN CONDITIONS OF GROWTH OF RESISTANCE OF UROPATHOGENES TO NEW GENERATIONS OF ANTIMICROBATES-Reference-Cited by-同舟云学术

JUSTIFICATION OF NITROXOLINE APPLICATION IN CONDITIONS OF GROWTH OF RESISTANCE OF UROPATHOGENES TO NEW GENERATIONS OF ANTIMICROBATES

Published:2023-12-30 Issue:2 Volume:1 Page:52-59
ISSN:2786-9288
Container-title:Ukrainian Journal of Laboratory Medicine
language:
Short-container-title:ujlm

Author:

Syrota Н. I.,Platonova I. L.

Abstract

Nitroxoline is a synthetic uroantiseptic, effective against a wide range of gram-positive, gram-negative bacteria and fungi. For a long time it has been used for the treatment and prevention of acute, chronic and recurrent urinary tract infections, because to this day retains high activity against bacteria of the family Enterobacteriaceae. With increasing resistance of uropathogens to new antimicrobial drugs, Nitroxoline may be an alternative drug for the treatment of acute uncomplicated urinary tract infections. The results of scientific research on the importance of Nitroxoline as a first-line drug in the treatment of this nosological group of diseases are contradictory. This motivates the study and analysis of the professional literature in the direction of clinical efficacy and determining the place of Nitroxoline among other uroseptics in the treatment of urinary tract infections in today's conditions.

Publisher

Civic organization "Clinical Laboratory Diagnostics Educational Institute" (CLADEI)

Reference37 articles.

1. Nitroksolin. Instruktsiia. Nakaz MOZ Ukrainy 08.07.2015 № 418. Reiestratsiine posvidchennia № UA/3518/01/01.

2. National Antibiotic Susceptibility Testing Committee (Germany): Nitroxoline. Rationale for the NAK Clinical Breakpoints. [Internet]. URL: https://www.nak-deutschland.org/tl_files/nak-deutschland/Nitroxoline_rationale_V_1.0_31012014.pdf

3. Amgar A. Activity in vitro of urine samples from patients treated by nitroxoline against mycoplasmas. J Chemother. 1989;4:226–8.

4. Hernández Molina JM, Llosá J, Ventosa A. In vitro activity of nitroxoline against clinical isolates of Candida species. Mycoses. 1991;34:823–5.

5. Kresker M, Körber-Irrgang B, on behalf of the Working Party Antimicrobial Resistance of the Paul Ehrlich society of Chemotherapy: In vitro activity of niroxoline against urine isolates of Echerichia coli from the community: results of a German multicentre study [Abstract]. In 23rd European Congress of Clinical Microbiology and Infections Diseases (23rd ECCMID): 27-30 April 2013